References
- Gatter K C, Warnke R A. Intravascular large B-cell lymphoma. World Health Organization Classification of Tumours, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC, Lyon 2001; 177–178
- Ferreri A JM, Campo E, Ambrosetti A, Ilariuccu F, Seymour J F, Willemze R, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma Ann Oncol 2004; 15: 1215–1221
- Ito M, Kim Y, Choi J W, Ozawa H, Fujino M. Prevalence of intravascular large B-cell lymphoma with bone marrow involvement at initial presentation. Int J Hematol 2003; 77: 159–163
- Kidson-Gerber G, Bosco A, MacCallum S, Dunkley S. Two cases of intravascular lymphoma highlighting the diagnostic difficulties in pyrexia of unknown origin. Int Med J 2005; 35: 569–570
- Dufau J P, Le Tourneau A, Molina T, Le Houcq M, Claessens Y E, Rio B, et al. Intravascular large B-cell lymphoma with bone marrow involvement at presentation and haemophagocytic syndrome: two Western cases in favour of a specific variant. Histopathology 2000; 37: 509–512
- Bouzani M, Karmiris T, Rontogianni D, Delimpassi S, Apostolidis J, Mpakiri M, et al. Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. Oncologist 2006; 11: 923–928
- Jardin F, Callonnec F, Contentin N, Picquenot J M, Gueit I, Heron F, et al. Intravascular large B-cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen. Clin Lymphoma 2005; 6: 46–49
- Moule S, Pancham S, Naresh K, Ryley S, Philpott N, Abrahamson G, et al. A case of intravascular large B-cell lymphoma with a complex karyotype including t(3;14), t(2;9) and abnormalities of 6q11 treated successfully with R-CHOP chemotherapy. Br J Haematol 2006; 133(Suppl 1)106
- Bazhenova L, Higginbottom P, Mason J. Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma 2006; 47: 337–341